申请人:IMARX THERAPEUTICS INC
公开号:WO2001010450A1
公开(公告)日:2001-02-15
Biocompatible, non-immunoreactive polymers are used in combination with both tissue or cellular receptor targeting ligands and thrombolytic agents to affect long acting yet localized lysis of thrombi.